TOGETHER WE CAN FIND A CURE

Let's Save the First Child from Duchenne muscular dystrophy

TOGETHER WE CAN FIND A CURE

Let's Save the First Child from Duchenne muscular dystrophy

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

PENNIES FOR HOPE

13 cents a day can save a child

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

TOGETHER WE CAN FIND A CURE

Let's Save the First Child from Duchenne muscular dystrophy

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Because no child should have to suffer like this.

Duchenne muscular dystrophy (DMD) is one of the rarest diseases on Earth. DMD is a fatal, muscle-wasting disease you are born with. It occurs once in every 3,500 live births and effects mostly boys. In the United States, with a population of over 330,000,000 people, only about 20,000 children are stricken with Duchenne. And there is no cure.


Our goal is to find a cure for Duchenne muscular dystrophy. With organized fundraising events and support from you, we can continue our mission and turn the dream of finding a cure into a reality.

LEARN MORE

Together, JAR of Hope has

RAISED $7 MILLION+

HELPED OVER 25+ FAMILIES

SPREAD AWARENESS GLOBALLY

Together, JAR of Hope has

RAISED $7 MILLION+

HELPED OVER 25+ FAMILIES

SPREAD AWARENESS GLOBALLY

Duchenne Muscular Dystrophy Clinical Trial 

We have partnered with the University of Florida College of Medicine and RESTEM LLC to to initiate an important trial for Duchenne muscular dystrophy (DMD).


Authorization has been granted to begin Phase 1 of the trial. Here, a "randomized, double-blind, placebo-controlled Cross Over study to assess the safety, tolerability, and preliminary efficacy of Umbilical Cord Lining stem cells (ULSC) in Pediatric patients with Duchenne muscular dystrophy (DMD).”

LEARN MORE ABOUT THE TRIAL

In the News

07 Apr, 2023
Nebraska man joins fight against Duchenne muscular dystrophy
29 Mar, 2023
Will you accept this challenge Millstone Twp. & Upper Freehold Regional School Districts? 
READ THE NEWS
Share by: